ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
Closed over Christmas
(reopened 1 February 2017)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Disturbed metabolic pathways
Sunday 15 July 2012
Armstrong and colleagues at University of Melbourne published results of a preliminary study analyzing blood samples from 11 CFS patients (2003, Carruthers clinical definition) and 10 non-fatigued controls to identify metabolites as biomarkers for CFS using H NMR spectroscopy. They found significantly decreased levels of glutamine and ornithine in CFS blood samples. They conclude, “Further metabolic analyses … are warranted to improve the knowledge of these metabolite changes and to draw more insight into the underlying biochemical pathways for possible etiologic and clinical significance.” (Clinica Chimica Acta, June 15, 2012)
The above originally appeared here.
blog comments powered by Disqus